{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Vivimed Labs Ltd is Rated Strong Sell
Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 May 2026, reflecting a significant reassessment of the stock’s outlook. However, the analysis presented here is based on the company’s current fundamentals, returns, and financial metrics as of 18 June 2026, providing investors with an up-to-date perspective on the stock’s position.
Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight
At Rs 6.08, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 5% on 8 Jun 2026, with unfilled sell orders and a frozen price, signalling a pronounced imbalance between supply and demand.
Vivimed Labs Ltd is Rated Strong Sell
Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 June 2026, providing investors with the latest insights into its performance and outlook.
Vivimed Labs Ltd Locks at Upper Circuit With 1.4% Gain — Buyers Queue, Sellers Absent
At Rs 6.77, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 5% on 29 May 2026, with buyers queuing and no sellers willing to part with shares.
When is the next results date for Vivimed Labs Ltd?
The next results date for Vivimed Labs Ltd is 30 May 2026.
Vivimed Labs Ltd is Rated Strong Sell
Vivimed Labs Ltd is rated 'Strong Sell' by MarketsMOJO, with this rating last updated on 12 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 May 2026, providing investors with the latest insights into the company's performance and outlook.
Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight
At Rs 6.27, Vivimed Labs Ltd locked at its lower circuit of 5% on 18 Jun 2026, with persistent unfilled supply as sellers queued but buyers remained absent. The price band capped the daily loss, freezing trading and highlighting the liquidity challenges faced by this micro-cap stock.
Vivimed Labs Ltd Falls 4.07%: Downgrade and Volatile Trading Mark the Week
Vivimed Labs Ltd experienced a challenging week on the BSE, closing at Rs.6.60 on 15 May 2026, down 4.07% from the previous Friday’s close of Rs.6.88. This underperformance came despite the broader Sensex falling 2.63% over the same period, indicating that Vivimed Labs declined more sharply than the market benchmark. The week was marked by a significant downgrade to a Strong Sell rating, followed by two consecutive days of upper circuit hits driven by strong buying pressure, reflecting a complex interplay of fundamental weakness and short-term speculative interest.
Vivimed Labs Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
At Rs 6.90, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 5% on 15 May 2026, with buyers queuing and no sellers willing to part with shares.
Vivimed Labs Ltd Locks at Upper Circuit With 4.88% Gain — Buyers Queue, Sellers Absent
At Rs 6.66, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 4.88% on 14 May 2026, with buyers queuing and no sellers willing to part with shares.
Vivimed Labs Ltd Downgraded to Strong Sell Amidst Weak Financials and Technical Setbacks
Vivimed Labs Ltd has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 12 May 2026, reflecting deteriorating fundamentals and a shift in technical indicators. The micro-cap pharmaceutical company’s financial performance remains flat with mounting debt concerns, while technical trends have shifted from mildly bullish to sideways, signalling caution for investors.
Vivimed Labs Gains 1.78%: Technical Shift and Upper Circuit Spark Interest
Vivimed Labs Ltd recorded a modest weekly gain of 1.78%, closing at Rs.6.88 on 8 May 2026, outperforming the Sensex’s 1.25% rise over the same period. The week was marked by a technical upgrade in the company’s rating and a strong price surge culminating in an upper circuit hit, reflecting a mix of cautious optimism amid persistent fundamental challenges.
Vivimed Labs Ltd Locks at Upper Circuit With 3.14% Gain — Buyers Queue, Sellers Absent
At Rs 7.02, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Vivimed Labs Ltd locked at its upper circuit of 3.14% on 7 May 2026, with buyers queuing and no sellers willing to part with shares.
Vivimed Labs Ltd Upgraded to Sell on Technical Improvements Despite Weak Fundamentals
Vivimed Labs Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 5 May 2026, driven primarily by a shift in technical indicators despite persistent fundamental challenges. The micro-cap pharmaceutical company’s technical outlook has improved to mildly bullish, prompting a reassessment of its market stance, even as financial and valuation metrics remain under pressure.
Vivimed Labs Ltd Downgraded to Strong Sell Amid Weak Financials and Technical Deterioration
Vivimed Labs Ltd has seen its investment rating downgraded from Sell to Strong Sell, reflecting deteriorating fundamentals and a shift in technical indicators. The company’s micro-cap status, combined with weak financial trends and bearish technical signals, has prompted analysts to revise their outlook, signalling caution for investors amid ongoing challenges.
Vivimed Labs Ltd is Rated Strong Sell
Vivimed Labs Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 24 April 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock’s current position as of 26 April 2026, providing investors with the most up-to-date analysis.
Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight
At Rs 6.89, sellers were still queuing — but there were no buyers willing to take the other side. Vivimed Labs Ltd locked at its lower circuit of 5% on 22 Apr 2026, with unfilled sell orders and a frozen price.
Vivimed Labs Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight
At Rs 7.37, Vivimed Labs Ltd locked at its lower circuit of 5% on 20 Apr 2026, with unfilled sell orders and a frozen price. Sellers were lined up to exit, but buyers were absent, creating a supply glut that halted further declines.
Vivimed Labs Gains 15.75%: 3 Key Factors Driving the Week’s Rally
Vivimed Labs Ltd delivered a robust weekly performance, surging 15.75% from ₹6.73 to ₹7.79 between 13 and 17 April 2026, significantly outperforming the Sensex’s 2.33% gain over the same period. The stock’s rally was marked by two upper circuit hits amid strong buying interest, supported by a technical upgrade and rising delivery volumes, signalling renewed investor attention despite ongoing fundamental challenges.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
